Skip to content

PROPANC BIOPHARMA, INC.: filings

Every PROPANC BIOPHARMA, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 58 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-05-14fiscal Q3 2026401170001493152-26-023210
10-Q2026-02-17fiscal Q2 2026391070001493152-26-007052
10-Q2025-11-14fiscal Q1 202638730001493152-25-023213
10-K2025-09-29fiscal FY 202538750001493152-25-016069
10-Q2025-05-15fiscal Q3 2025351060001641172-25-010798
10-Q2025-02-14fiscal Q2 2025341010001493152-25-006697
10-Q2024-11-14fiscal Q1 202533670001493152-24-045664
10-K2024-09-30fiscal FY 202438770001493152-24-038815
10-Q2024-05-15fiscal Q3 2024371140001493152-24-019940
10-Q2024-02-20fiscal Q2 2024371100001493152-24-007191
10-Q2023-11-14fiscal Q1 202436720001493152-23-040980
10-K2023-09-28fiscal FY 202338800001493152-23-034632
10-Q2023-05-15fiscal Q3 2023381120001493152-23-017346
10-Q2023-02-10fiscal Q2 2023371070001493152-23-004150
10-Q2022-11-14fiscal Q1 202337740001493152-22-032116
10-K2022-09-28fiscal FY 202238760001493152-22-027033
10-Q2022-05-16fiscal Q3 2022361100001493152-22-013577
10-Q2022-02-14fiscal Q2 202233940001493152-22-004382
10-Q2021-11-12fiscal Q1 202232640001493152-21-028221
10-K2021-09-28fiscal FY 202137730001493152-21-023973
10-Q2021-05-14fiscal Q3 202133960001493152-21-011560
10-Q2021-02-12fiscal Q2 202132880001493152-21-003609
10-Q2020-11-16fiscal Q1 202131620001493152-20-021528
10-K2020-10-01fiscal FY 202036680001493152-20-018726
10-Q2020-05-15fiscal Q3 202032850001493152-20-009146
10-Q2020-02-14fiscal Q2 202030810001493152-20-002576
10-Q2019-11-14fiscal Q1 202031570001493152-19-017566
10-K2019-10-15fiscal FY 201932630001493152-19-015529
10-Q2019-05-15fiscal Q3 201929820001493152-19-007459
10-Q2019-02-14fiscal Q2 201929710001493152-19-002072
10-Q2018-11-13fiscal Q1 201924470001493152-18-015599
10-K2018-09-17fiscal FY 201830630001493152-18-013392
10-Q2018-05-10fiscal Q3 201825650001493152-18-006584
10-Q2018-02-09fiscal Q2 201824610001493152-18-001696
10-Q2017-11-09fiscal Q1 201823430001493152-17-012713
10-K2017-09-28fiscal FY 201728580001493152-17-011027
10-Q2017-05-08fiscal Q3 201724660001493152-17-004870
10-Q2017-02-14fiscal Q2 201723640001144204-17-008493
10-Q2016-11-10fiscal Q1 201723460001144204-16-133411
10-K2016-09-28fiscal FY 201628580001144204-16-125808
10-Q2016-05-16fiscal Q3 201625680001144204-16-102344
10-Q2016-02-16fiscal Q2 201625680001144204-16-082302
10-Q2015-11-16fiscal Q1 201624480001144204-15-065865
10-K2015-09-30fiscal FY 201529600001144204-15-057458
10-Q2015-05-15fiscal Q3 201526690001144204-15-031499
10-Q2015-02-17fiscal Q2 201526700001144204-15-009533
10-Q2014-11-19fiscal Q1 201524480001144204-14-069836
10-K2014-10-14fiscal FY 201428570001144204-14-060984
10-Q2014-05-20fiscal Q3 201428770001354488-14-002818
10-Q2014-02-14fiscal Q2 201429810001354488-14-000725
10-Q2013-11-14fiscal Q1 201428620001354488-13-006349
10-K2013-10-15fiscal FY 201333820001354488-13-005698
10-Q2013-05-20fiscal Q3 201329820001354488-13-003018
10-Q2013-02-20fiscal Q2 201329860001354488-13-000756
10-Q2012-11-19fiscal Q1 201330670001354488-12-006039
10-K2012-10-15fiscal FY 201233830001354488-12-005291
10-Q2012-05-21fiscal Q3 201229830001354488-12-002768
10-Q/A2012-03-07fiscal Q2 201229940001354488-12-001037

Inspect the source

Entity
PROPANC BIOPHARMA, INC. / CIK 0001517681
Captured
2026-09-20T09:14:07.933Z
SEC response SHA-256
4f6eac6bf72e7f988a9a94ea85589b445974414449c4b417540ed20477181487

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001517681.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))